Weidmann E - Search Results

1

Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma.

Weisel KC, Weidmann E, Anagnostopoulos I, Kanz L, Pezzutto A, Subklewe M. Weisel KC, et al. Among authors: weidmann e. Int J Hematol. 2008 Nov;88(4):434-440. doi: 10.1007/s12185-008-0176-2. Epub 2008 Oct 7. Int J Hematol. 2008. PMID: 18839273

2

A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas.

Weidmann E, Hess G, Chow KU, Krause SW, Subklewe M, Kruse J, Weisel KC, Soekler M, Kim SZ, Napieralski S, Rech J, Dreyling M, Jäger E, Mitrou PS. Weidmann E, et al. Leuk Lymphoma. 2010 Mar;51(3):447-55. doi: 10.3109/10428190903580402. Leuk Lymphoma. 2010. PMID: 20141439 Clinical Trial.

3

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.

Horwitz S, O'Connor OA, Pro B, Illidge T, Fanale M, Advani R, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WS, Feldman T, Lennard A, Belada D, Illés Á, Tobinai K, Tsukasaki K, Yeh SP, Shustov A, Hüttmann A, Savage KJ, Yuen S, Iyer S, Zinzani PL, Hua Z, Little M, Rao S, Woolery J, Manley T, Trümper L; ECHELON-2 Study Group. Horwitz S, et al. Lancet. 2019 Jan 19;393(10168):229-240. doi: 10.1016/S0140-6736(18)32984-2. Epub 2018 Dec 4. Lancet. 2019. PMID: 30522922 Free PMC article. Clinical Trial.

4

Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.

Coiffier B, Federico M, Caballero D, Dearden C, Morschhauser F, Jäger U, Trümper L, Zucca E, Gomes da Silva M, Pettengell R, Weidmann E, d'Amore F, Tilly H, Zinzani PL. Coiffier B, et al. Among authors: weidmann e. Cancer Treat Rev. 2014 Oct;40(9):1080-8. doi: 10.1016/j.ctrv.2014.08.001. Epub 2014 Aug 24. Cancer Treat Rev. 2014. PMID: 25199959 Free article. Review.

5

Peripheral T-cell lymphomas respond well to vincristine, adriamycin, cyclophosphamide, prednisone and etoposide (VACPE) and have a similar outcome as high-grade B-cell lymphomas.

Karakas T, Bergmann L, Stutte HJ, Jäger E, Knuth A, Weidmann E, Mitrou PS, Hoelzer D. Karakas T, et al. Among authors: weidmann e. Leuk Lymphoma. 1996 Dec;24(1-2):121-9. doi: 10.3109/10428199609045720. Leuk Lymphoma. 1996. PMID: 9049968 Clinical Trial.

6

Dexa-BEAM as salvage therapy in patients with primary refractory aggressive non-Hodgkin lymphoma.

Atta J, Chow KU, Weidmann E, Mitrou PS, Hoelzer D, Martin H. Atta J, et al. Among authors: weidmann e. Leuk Lymphoma. 2007 Feb;48(2):349-56. doi: 10.1080/10428190600880084. Leuk Lymphoma. 2007. PMID: 17325896

7

Cytotoxic hepatosplenic gammadelta T-cell lymphoma following acute myeloid leukemia bearing two distinct gamma chains of the T-cell receptor. Biologic and clinical features.

Weidmann E, Hinz T, Klein S, Schui DK, Harder S, Kriener S, Kabelitz D, Hoelzer D, Mitrou PS. Weidmann E, et al. Haematologica. 2000 Oct;85(10):1024-31. Haematologica. 2000. PMID: 11025592

8

Induction of apoptosis using 2',2' difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphatic and myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cells.

Chow KU, Ries J, Weidmann E, Pourebrahim F, Napieralski S, Stieler M, Boehrer S, Rummel MJ, Stein J, Hoelzer D, Mitrou PS. Chow KU, et al. Among authors: weidmann e. Ann Hematol. 2000 Sep;79(9):485-92. doi: 10.1007/s002770000181. Ann Hematol. 2000. PMID: 11043419

9

In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine.

Chow KU, Boehrer S, Geduldig K, Krapohl A, Hoelzer D, Mitrou PS, Weidmann E. Chow KU, et al. Among authors: weidmann e. Haematologica. 2001 May;86(5):485-93. Haematologica. 2001. PMID: 11410411

10

Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicine.

Weidmann E, Boehrer S, Chow KU, Engels K, Harder L, Hinz T, Janssen O, Kriener S, Rummel MJ, Siebert R, Kabelitz D, Hansmann ML, Hoelzer D, Mitrou PS; Study Group Peripheral T- and NK-Cell Neoplasias. Weidmann E, et al. Onkologie. 2001 Apr;24(2):162-4. doi: 10.1159/000050305. Onkologie. 2001. PMID: 11441297

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters